Table 1.
Patient characteristics
| Age (years) | 62 ± 14 |
| Sex (M/F) | 40/18 |
| Weight (kg) | 81 ± 24 |
| Height (cm) | 169 ± 12 |
| Body surface area (m2) | 1.88 ± 0.25 |
| Body mass index | 28 ± 8 |
| History of cardiac disease | 25 (43%) |
| History of vascular disease | 4 (7%) |
| Patient type | |
| Medical | 41 (71%) |
| Surgical (post-op.) | 13 (22%) |
| Trauma | 4 (7%) |
| Vasoactive support | |
| Norepinephrine | 39 (67%) |
| Vasopressin | 9 (16%) |
| Dopamine | 1 (2%) |
| Inotropic support | |
| Dobutamine | 16 (28%) |
| Milrinone | 7 (12%) |
| Levosimendan | 5 (9%) |
| Mechanical ventilation | 51 (88%) |
| Hemodynamic profile (aggregate measurements over the entire study period) | |
| Heart rate (bpm) | 97 ± 19 |
| Mean arterial pressure (mmHg) | 76 ± 11 |
| iCO (L/min) | 7.5 ± 2.0 |
| COG2 (L/min) | 6.5 ± 1.5 |
| COG3 (L/min) | 7.3 ± 2.1 |
| CCO (L/min) | 8.1 ± 2.1 |
| TSVR (dyn/(s cm5)) | 875 ± 283 |
TSVR total systemic vascular resistance; iCO cardiac output measured by bolus thermodilution; CO G2 cardiac output measured by second-generation FloTrac; CO G3 cardiac output measured by third-generation FloTrac; CCO cardiac output measured by semi-continuous thermodilution